Evidence map›Paper›PMID 28765173›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

A

Balázs Csóka, Gábor Törő, Joana Vindeirinho, Zoltán V Varga, Balázs Koscsó, Zoltán H Németh, Endre Kókai, Luca Antonioli, Mara Suleiman, Piero Marchetti and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. APurinergic signalling · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The adenosine pathway in immuno-oncology.Nature reviews. Clinical oncology · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Balázs CsókaDepartment of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA; csokaba@njms.rutgers.edu.
Gábor TörőDepartment of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Joana VindeirinhoDepartment of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Zoltán V VargaNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Balázs KoscsóDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Zoltán H NémethDepartment of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Endre KókaiDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Luca AntonioliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Mara SuleimanDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Piero MarchettiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Karolina CseriDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Ádám DeákDepartment of Operative Techniques and Surgical Research of the Institute of Surgery, University of Debrecen, Debrecen, Hungary; and.
László VirágDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Pál PacherNational Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
Péter BaiDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
György HaskóDepartment of Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA; haskoge@njms.rutgers.edu.
University of Debrecen · HUHungarian Academy of Sciences · HURutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · USMorristown Medical Center · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institutes of Health · USPennsylvania State University · USUniversity of Pisa · IT

Funding

Purinergic signaling in trauma and sepsisR01GM066189 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HASKO, GEORGE · 2002 to 2020
$4.7M
Purinergic signaling in granuloma-forming Th2 immunityR01DK113790 · NIDDK · RBHS-NEW JERSEY MEDICAL SCHOOL · PI GAUSE, WILLIAM CLARK, HASKO, GEORGE · 2017 to 2020
$1.9M
NIDDK NIH HHS R01 DK113790NIGMS NIH HHS R01 GM066189
6 · The paper itself

Abstract

Adenosine, a key extracellular signaling mediator, regulates several aspects of metabolism by activating 4 G-protein-coupled receptors, the A

Indexed as

AnimalsAntigens, DifferentiationDietary FatsGene Expression RegulationInsulin-Secreting CellsMiceMice, KnockoutObesityPancreatic DiseasesReceptor, Adenosine A2AAntigens, DifferentiationDietary FatsReceptor, Adenosine A2Adiabetesisletβ-cellβ-cell dedifferentiation

Identifiers

PMID28765173
PMCPMC5636705
OpenAlexW2739681828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.